Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy A Grabner, AP Amaral, K Schramm, S Singh, A Sloan, C Yanucil, J Li, ... Cell metabolism 22 (6), 1020-1032, 2015 | 573 | 2015 |
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease S Singh, A Grabner, C Yanucil, K Schramm, B Czaya, S Krick, MJ Czaja, ... Kidney international 90 (5), 985-996, 2016 | 348 | 2016 |
FGF23/FGFR4-mediated left ventricular hypertrophy is reversible A Grabner, K Schramm, N Silswal, M Hendrix, C Yanucil, B Czaya, ... Scientific reports 7 (1), 1993, 2017 | 136 | 2017 |
Fibroblast growth factor 23 and Klotho contribute to airway inflammation S Krick, A Grabner, N Baumlin, C Yanucil, S Helton, A Grosche, J Sailland, ... European Respiratory Journal 52 (1), 2018 | 109 | 2018 |
Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats M Leifheit-Nestler, A Grabner, L Hermann, B Richter, K Schmitz, ... Nephrology Dialysis Transplantation 32 (9), 1493-1503, 2017 | 95 | 2017 |
Cardioprotective effects of paricalcitol alone and in combination with FGF23 receptor inhibition in chronic renal failure: experimental and clinical studies B Czaya, W Seeherunvong, S Singh, C Yanucil, P Ruiz, Y Quiroz, ... American journal of hypertension 32 (1), 34-44, 2019 | 30 | 2019 |
Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease C Yanucil, D Kentrup, I Campos, B Czaya, K Heitman, D Westbrook, ... Kidney international 102 (2), 261-279, 2022 | 29 | 2022 |
Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling B Czaya, K Heitman, I Campos, C Yanucil, D Kentrup, D Westbrook, ... Elife 11, e74782, 2022 | 26 | 2022 |
STAT3-enhancing germline mutations contribute to tumor-extrinsic immune evasion D Kogan, A Grabner, C Yanucil, C Faul, VK Ulaganathan The Journal of clinical investigation 128 (5), 1867-1872, 2018 | 24 | 2018 |
FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetes C Yanucil, D Kentrup, X Li, A Grabner, K Schramm, EC Martinez, J Li, ... Scientific reports 12 (1), 7326, 2022 | 13 | 2022 |
FGFR4 does not contribute to progression of chronic kidney disease A Taylor, C Yanucil, J Musgrove, M Shi, S Ide, T Souma, C Faul, M Wolf, ... Scientific Reports 9 (1), 14023, 2019 | 13 | 2019 |
A klotho-derived peptide as a possible novel drug to prevent kidney fibrosis T Isakova, C Yanucil, C Faul American Journal of Kidney Diseases 80 (2), 285-288, 2022 | 8 | 2022 |
Hyperphosphatemia contributes to inflammation and iron dysregulation in models of normal and impaired renal function B Czaya, B Richter, C Yanucil, I Campos, K Heitman, C Faul Blood 134, 2238, 2019 | 7 | 2019 |
Induction of an inflammatory response in primary hepatocyte cultures from mice B Czaya, S Singh, C Yanucil, K Schramm, C Faul, A Grabner Journal of visualized experiments: JoVE, 2017 | 6 | 2017 |
Klotho: A Large Protein with Various Beneficial Functions, but also with Therapeutic Value? C Yanucil, C Faul Journal of the American Society of Nephrology, 10.1681, 2024 | | 2024 |
Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in the Absence and Presence of Chronic Kidney Disease K Heitman, B Czaya, I Campos, C Yanucil, D Kentrup, D Westbrook, ... The FASEB Journal 36, 2022 | | 2022 |
Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in the Absence and Presence of CKD: PO0531 K Heitman, BA Czaya, ID Campos, C Yanucil, D Kentrup, DG Westbrook, ... Journal of the American Society of Nephrology 32 (10S), 204, 2021 | | 2021 |
Hyperphosphatemia Contributes to Skeletal Muscle Atrophy in Chronic Kidney Disease K Heitman, B Czaya, B Richter, I Campos, C Yanucil, D Kentrup, ... The FASEB Journal 35, 2021 | | 2021 |
Paracrine FGF-23 Signaling in the Heart Causes Cardiac Hypertrophy: SA-OR34 ID Campos, B Richter, C Yanucil, BA Czaya, K Heitman, D Kentrup, ... Journal of the American Society of Nephrology 31 (10S), 40, 2020 | | 2020 |
Hyperphosphatemia Contributes to Inflammation, Iron Dysregulation, and Skeletal Muscle Wasting: PO0324 BA Czaya, K Heitman, ID Campos, C Yanucil, D Kentrup, C Faul Journal of the American Society of Nephrology 31 (10S), 149-150, 2020 | | 2020 |